The Committee for Medicinal Products for Human Use (CHMP), of the European Medicines Agency (EMA), has issued a positive opinion for three new…
I’m writing this blog post from an unusual location – my kitchen. Typically, I prefer typing away at obscure hours of the night in the…
This year the AADE Annual Meeting will take place August 7-10 in Philadelphia. We'll be sharing live updates and tweets from the meeting, so be sure to follow us on Twitter @A_Sweet_Life and Facebook to get the updates as they appear.
British Home Secretary, Theresa May, has revealed her recent diagnosis with type 1 diabetes.
According to a BBC report doctors initially thought Mrs May had type 2 diabetes, but two months ago it was revealed to be type 1 diabetes.
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has concluded that presently available data does not confirm recent concerns over an increased risk of pancreatic adverse events with GLP-1-based diabetes therapies.
AstraZeneca and Bristol-Myers Squibb Company resubmitted a New Drug Application (NDA) to the U.S. FDA for the investigational drug dapagliflozin for the treatment of adults with type 2 diabetes. The FDA assigned a new Prescription Drug User Fee Act (PDUFA) goal date of Jan. 11, 2014.
Medicare and the FDA (Food and Drug Administration) are choosing to lower costs at the expense of your health. They are allowing cheap and faulty…
In anticipation of stable, liquid glucagon, one of the newest entrants into the insulin pump space, Tandem Diabetes Care has jumped ahead of the crowd and created a two-chamber infusion pump capable of holding and injecting both insulin and a secondary hormone, which they expect will be glucagon. This tandem Tandem pump is already being tested in Dr. Ed Damiano's clinical trial of a dual-hormone bionic pancreas.
There are just two days left to enter the DiabetesMine PATIENT VOICES SCHOLARSHIP CONTEST!
Winners will get a free trip to California to take part in our 2013 DiabetesMine Innovation Summit this fall at Stanford University.
I like to think that diabetes hasn’t changed me — and indeed, in most ways I think I’m still the person I was before I was diagnosed…